Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence for drug design, announced today that it has secured the #1 global ranking for new U.S. patent families in AI Drug Discovery ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome sequencing, metabolomics, and systems biology have generated vast datasets, but ...

The global artificial intelligence (AI) in drug discovery market is experiencing rapid expansion, driven by the need to reduce the high costs and long timelines of traditional pharmaceutical ...

In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

SAN FRANCISCO (KRON) – As the use of artificial intelligence becomes a more popular tool in drug research, a scientific software company aims to one day use the technology to predict future medicines.

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...